Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Plan Seeks to Slash Industry Influence on Doctors

By Pharmaceutical Processing | April 1, 2009

LINDSEY TANNER AP Medical Writer CHICAGO (AP) — In a drastic proposal for limiting drug company influence on doctors and patient care, a group of prominent physicians says medical associations and their leaders should reject almost all industry funding. That means big medical groups would need to find other ways to pay for things like doctors’ continuing education classes, or gatherings where treatment guidelines are written. Guideline writers also should have no industry ties, the proposal recommends. Some “sacrifice” likely would result — fewer events or higher membership dues, the proposal suggests. “It has not always been flattering to see how physicians’ relationships to industry appear to have colored their judgment in matters of public health,” said Dr. Steven Nissen, a proposal co-author and former president of the American College of Cardiology. Examples include disease treatment guidelines recommending certain drugs, written by doctors who own stock in those drugs’ makers. Or, medical meetings where doctors tote around book bags, pens and identification badges emblazoned with drug company logos. Some groups have eliminated those freebies, but the proposal — appearing in Wednesday’s Journal of the American Medical Association — says they should work toward a complete ban on industry funding. One exception is money paid for medical meeting exhibits, where drug and device makers display their wares. Doctors “can easily distinguish these marketing activities from educational presentations,” the proposal says. Another such exception cited is advertising in medical journals that helps finance journal operations. Industry funding of research by medical groups and their members should come with no strings attached and the organizations, not drug makers, should decide how to use it, the proposal says. It joins the growing calls for more restrictions to prevent inappropriate drug company influence on patient care. Some medical schools, doctor and industry groups have already adopted limits or sought more disclosure. The new proposal’s 11 authors include Dr. Catherine DeAngelis, JAMA’s editor-in-chief; Dr. James Scully, CEO of the American Psychiatric Association, and Dr. Gerald Thomson, former president of the American College of Physicians. It reflects their opinions, not those of their medical groups. Dr. Jerome Kassirer, a longtime critic of doctor-industry ties, praised the proposal but said it’s unlikely to be fully adopted by large medical groups, which depend on industry funding for many activities. Dr. Joseph M. Heyman, chairman of the AMA’s board, said in a written statement that the AMA has limits including restrictions on drug company gifts to physicians, but he did not indicate if the group would consider adopting harsher limits.

Related Articles Read More >

Driving success in fast-paced high-tech pharma construction projects
This is a photo of the Fujifilm Diosynth Biotechnologies plant under construction in Holly Springs, North Carolina.
Fujifilm, Regeneron ink $3B U.S. manufacturing agreement
This is the logo of Johnson & Johnson.
J&J breaks ground on $2B manufacturing facility in North Carolina
sherwin-williams-pharma-facility (1)
Sherwin-Williams expands flooring solutions for pharma facilities
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE